Back

Long-term safety and efficacy of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalaemia: interim analysis of ZS-005, an open-label phase 3 study

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30 Drug therapy, other HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

22 More presentations in this session

Presentation thumbnail
Zofenopril combined with xanthine oxidase inhibitors may improve survival in post-myocardial infarction patients as compared to placebo or other ACE-inhibitors
Presentation thumbnail
Long-term effects and sustainability of collaborative disease management in systolic heart failure - the extended interdisciplinary network heart failure study
Professor C. Angermann (Wurzburg, DE)
Presentation thumbnail
An implantable pressure sensor for long-term wireless monitoring of cardiac function -first study in man
Doctor J. Baranowski (Linkoping, SE)
Presentation thumbnail
Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time in EMPA-REG OUTCOME
Doctor D. Fitchett (Toronto, CA)
Presentation thumbnail
Characteristics of myocardial deformation parameters and their prognostic impact in patients with hypertrophic cardiomyopathy: a speckle tracking imaging analysis
Doctor S. Charfeddine (Sfax, TN)

Access the full session

Session thumbnail
Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources